British Columbia’s Health Ministry is limiting the sales of two more Type 2 diabetes drugs, tirzepatide (Mounjaro) and dulaglutide (Trulicity), to curb their off-label use for weight loss and preserve supply for diabetic patients. This follows a 2023 regulation for semaglutide (Ozempic). The new rules restrict sales to non-citizens or non-permanent residents of Canada who are not physically present at a pharmacy, aiming to address drug shortages in several countries, including the United States.
B.C. limits sales of two more diabetes drugs used for weight loss
Diabetes weight loss drugsHealthPolitics
AI Summary
TL;DR: Key points with love ❤️British Columbia’s Health Ministry is limiting the sales of two more Type 2 diabetes drugs, tirzepatide (Mounjaro) and dulaglutide (Trulicity), to curb their off-label use for weight loss and preserve supply for diabetic patients. This follows a 2023 regulation for semaglutide (Ozempic). The new rules restrict sales to non-citizens or non-permanent residents of Canada who are not physically present at a pharmacy, aiming to address drug shortages in several countries, including the United States.
Trending- 1 2023: Regulation limited sales of semaglutide (Ozempic).
- 2 July 17, 2025: B.C. Health Ministry limits sales of tirzepatide and dulaglutide.
- Preservation of drug supply for diabetic patients
- Potential impact on non-residents seeking these drugs for weight loss
- Continued efforts to ensure access for diabetics
What: British Columbia's Health Ministry is limiting the sales of two more diabetes drugs (tirzepatide and dulaglutide).
When: Announced on July 17, 2025; following a 2023 regulation.
Where: British Columbia, Canada.
Why: To curb off-label use for weight loss, preserve supply for diabetic patients, and address drug shortages in several countries including the United States.
How: By implementing rules that prevent B.C. pharmacists from selling the drugs to non-citizens or non-permanent residents of Canada who are not at the pharmacy in person. The College of Pharmacists of B.C. is responsible for ensuring compliance.